United States · Funded startup

Who invested in Cura Partners

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Cannabis

Funding summaryUpdated 15 Nov 2026

$75Mraised across 1 round since 2018, from 1 source

Latest round
Round, $75MNov 2018
Investors
0
See who backed them

The rounds

  1. Nov 2018
    Round$75M

    No investor was named in the report.

    Reported by FinSMEsSEC filing: $40M sold, first sale Nov 2018

Funding filed with regulators

Cura Partners filed 3 raises, $87M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Nov 2018$40M58 investorsequity, debt, securities on exercise, otherSEC Form D
  2. May 2018$34M15 investorsequity, debt, securities on exerciseof $45M offeredSEC Form D
  3. Sept 2017$13M7 investorsequity, debt, securities on exerciseSEC Form D

Founders and team

From the SEC filings it signed: 5 on the team.

  • Amy McClintickExecutive Officeri
  • Amy StephensonExecutive Officeri
  • Cameron ForniExecutive Officer, Directori
  • Chris EsslerExecutive Officeri
  • David ThompsonExecutive Officeri

On the board, as filediBoris JordanNick SlindeNitin KhannaTodd Goergen

Quick answers about Cura Partners

How much has Cura Partners raised?

Cura Partners has raised $75M across 1 round since 2018.

When did Cura Partners last raise?

Cura Partners's most recent round was an Undisclosed round of $75M in Nov 2018.

What was Cura Partners's biggest round?

Its most recent round, $75M in Nov 2018, is also its largest on record.

What stage is Cura Partners at?

Cura Partners's latest named round is an Undisclosed round, in Nov 2018.

Where is Cura Partners based?

Cura Partners is based in the United States.

Companies like Cura Partners

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.